Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Oncternal Therapeutics Inc. (ONCT) (ONCT)

2.85   0.22 (8.37%) 04-03 16:00
Open: 3.39 Pre. Close: 2.63
High: 3.39 Low: 2.76
Volume: 7,983 Market Cap: 44M
Oncternal Therapeutics, Inc., a clinical-stage biotechnology company, develops various product candidates for the treatment of cancer. The company's product pipeline includes cirmtuzumab, a monoclonal antibody designed to inhibit the receptor tyrosine kinase-like orphan receptor 1 (ROR1) that is being evaluated in a Phase I/II clinical trial in combination with ibrutinib for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma; and TK-216, a small-molecule compound that is designed to inhibit E26 transformation-specific oncogene-family oncoproteins, which is being evaluated in a Phase I clinical trial alone and in combination with vincristine to treat Ewing sarcoma, a rare pediatric cancer. It is also developing a chimeric antigen receptor-T product candidate that targets ROR1, which is currently in preclinical development for treating hematologic cancers and solid tumors. The company is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.393 - 3.41 3.41 - 3.424
Low: 2.727 - 2.743 2.743 - 2.757
Close: 2.826 - 2.851 2.851 - 2.872

Technical analysis

as of: 2020-04-03 4:39:32 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.04     One year: 4.92
Support: Support1: 2.24    Support2: 1.86
Resistance: Resistance1: 3.46    Resistance2: 4.21
Pivot: 2.84
Moving Average: MA(5): 2.87     MA(20): 2.99
MA(100): 4.19     MA(250): 5.33
MACD: MACD(12,26): -0.24     Signal(9): -0.27
Stochastic oscillator: %K(14,3): 36.48     %D(3): 37.57
RSI: RSI(14): 42.99
52-week: High: 9.80  Low: 2.24  Change(%): -67.9
Average Vol(K): 3-Month: 1529  10-Days: 1104

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ONCT has closed below upper band by 49.1%. Bollinger Bands are 2.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 03 Apr 2020
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Apple, Tyson Foods, Under Armour

Wed, 11 Mar 2020
Health Care Sector Update for 03/11/2020: AYTU,ONCT,JNJ,ABBV,DXC,SEEL

Wed, 11 Mar 2020
Health Care Sector Update for 03/11/2020: SEEL,DXC,ONCT,JNJ,ABBV

Thu, 12 Dec 2019
First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges

Mon, 14 Oct 2019
5 Top Gainers In Healthcare Sector (ONCT, DMAC, INMD…)

Thu, 07 Mar 2019
Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15.39
Shares Float (M)
% Held by Insiders 29.21
% Held by Institutions 8.23
Shares Short (K) 83
Shares Short P. Month (K) 81

Stock Financials

EPS -0.584
Book Value (p.s.) 1.180
PEG Ratio
Profit Margin
Operating Margin -619.38
Return on Assets (ttm) -43.0
Return on Equity (ttm) -214.1
Qtrly Rev. Growth 54.3
Gross Profit (p.s.) 0.157
Sales Per Share 0.157
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -16.75
Levered Free Cash Flow (M) -6.65

Stock Valuations

P/E -4.88
P/E Growth Ratio 0.08
P/BV 2.42
P/CF -2.62

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-06-09
Last Split Ratio 0.14
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.